Fabrice Plasson
Chairman en Amoeba US Corp. .
Perfil
Fabrice Plasson founded Amoéba SA in 2010 and served as President & Chief Executive Officer until 2015.
He is also the founder of Eurofins DiscoverX Corp., Inc., EUROFINS DISCOVERX PRODUCTS FRANCE.
Currently, he serves as Chairman at Amoeba US Corp.
and Entreprise Amoeba Canada, Inc. He previously worked as a Principal at Whatman Ltd.
Mr. Plasson holds an MBA from EM Lyon Business School and a graduate degree from Université Joseph Fourier.
Cargos activos de Fabrice Plasson
Empresas | Cargo | Inicio |
---|---|---|
Amoeba US Corp. | Chairman | - |
Entreprise Amoeba Canada, Inc. | Chairman | - |
Antiguos cargos conocidos de Fabrice Plasson.
Empresas | Cargo | Fin |
---|---|---|
AMOÉBA | Chief Executive Officer | 14/12/2023 |
EUROFINS DISCOVERX PRODUCTS FRANCE
EUROFINS DISCOVERX PRODUCTS FRANCE Miscellaneous Commercial ServicesCommercial Services EUROFINS DISCOVERX PRODUCTS FRANCE provides functional cell-based assays to analyze signaling, dimerization, internalization, and clustering/crosslinking of checkpoint receptors. The private company is based in Celle-L Evescault, France. The French company also offers GPCR and ion channel membrane preps for determining ligand binding affinities and performing functional studies to evaluate GPCR activity in response to a ligand or therapeutic. Additionally, they provide pharmacologically and functionally validated ion channel cell lines, voltage-gated, ligand-gated and other ion channels products for discovery and safety applications. The company was founded by Fabrice Plasson. | Chief Executive Officer | - |
Whatman Ltd. | Corporate Officer/Principal | - |
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Founder | - |
Formación de Fabrice Plasson.
EM Lyon Business School | Masters Business Admin |
Université Joseph Fourier | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AMOÉBA | Consumer Non-Durables |
Empresas privadas | 5 |
---|---|
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Health Technology |
Whatman Ltd. | |
Amoeba US Corp. | |
Entreprise Amoeba Canada, Inc. | |
EUROFINS DISCOVERX PRODUCTS FRANCE
EUROFINS DISCOVERX PRODUCTS FRANCE Miscellaneous Commercial ServicesCommercial Services EUROFINS DISCOVERX PRODUCTS FRANCE provides functional cell-based assays to analyze signaling, dimerization, internalization, and clustering/crosslinking of checkpoint receptors. The private company is based in Celle-L Evescault, France. The French company also offers GPCR and ion channel membrane preps for determining ligand binding affinities and performing functional studies to evaluate GPCR activity in response to a ligand or therapeutic. Additionally, they provide pharmacologically and functionally validated ion channel cell lines, voltage-gated, ligand-gated and other ion channels products for discovery and safety applications. The company was founded by Fabrice Plasson. | Commercial Services |
- Bolsa de valores
- Insiders
- Fabrice Plasson